Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 41, Issue 2, 2009, Pages 199-206

  Bergamini, Gabriella ^a   Cigana, Cristina ^a   Sorio, Claudio ^b   Della Peruta, Marco ^b   Pompella, Alfonso ^c   Corti, Alessandro ^c   Huaux, Francxois A ^d   Leal, Teresinha ^d   Assael, Baroukh M ^a   Melotti, Paola ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

glutamyltransferase; Azithromycin; Cystic fibrosis; Glutathione S transferases; Inflammation

Indexed keywords

AZITHROMYCIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; INTERLEUKIN 10; MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HOMOZYGOTE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AZITHROMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; INTERLEUKIN-8; ISOENZYMES; MICE; MICE, TRANSGENIC; OXIDATION-REDUCTION; RESPIRATORY MUCOSA; SULFHYDRYL COMPOUNDS; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 67651155937     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0013OC     Document Type: Article

References (48)

1. Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 1999;79:S23-S45.
2. Gao L, Kim KJ, Yankaskas JR, Forman HJ. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol 1999;277:L113-L118.
3. Kogan I, Ramjeesingh M, Li C, Kidd JF, Wang Y, Leslie EM, Cole SP, Bear CE. CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J 2003;22:1981-1989.
4. Linsdell P, Hanrahan JW. Glutathione permeability of CFTR. Am J Physiol 1998;275:C323-C326.
5. Roum JH, Buhl R, McElvaney NG, Borok Z, Crystal RG. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 1993;75:2419-2424.
6. Day BJ, van Heeckeren AM, Min E, Velsor LW. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary Pseudomonas infection. Infect Immun 2004;72:2045-2051.
7. Cigana C, Assael BM, Melotti P. Azithromycin selectively reduces tumor necrosis factor falphag in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother 2007;51:975-981.
8. Cigana C, Nicolis E, Pasetto M, Assael BM, Melotti P. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 2006;350:977-982.
9. Garg AK, Aggarwal BB. Reactive oxygen intermediates in TNF signaling. Mol Immunol 2002;39:509-517.
10. van Doorninck JH, French PJ, Verbeek E, Peters RH, Morreau H, Bijman J, Scholte BJ. A mouse model for the cystic fibrosis delta F508 mutation. EMBO J 1995;14:4403-4411.
11. Zeitlin PL, Lu L, Rhim J, Cutting G, Stetten G, Kieffer KA, Craig R, Guggino WB. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol 1991;4:313-319.
12. Cozens AL, Yezzi MJ, Chin L, Simon EM, Finkbeiner WE, Wagner JA, Gruenert DC. Characterization of immortal cystic fibrosis tracheobronchial gland epithelial cells. Proc Natl Acad Sci USA 1992;89:5171-5175.
13. Di Paolo A, Barbara C, Chella A, Angeletti CA, Del Tacca M. Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily. Pharmacol Res 2002;46:545-550.
14. Kawamura-Sato K, Iinuma Y, Hasegawa T, Horii T, Yamashino T, Ohta M. Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis. Antimicrob Agents Chemother 2000;44:2869-2872.
15. Perussia B, Chan SH, D'Andrea A, Tsuji K, Santoli D, Pospisil DM, Young D, Wolf SF, Trinchieri G. Natural killer cell stimulatory factor or interleukin-12 has differential effects on the proliferation of TCR β+ TCRγδ T lymphocytes and NK cells. J Immunol 1992;149:3495-3502.
16. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, Illgen-Wilcke B. FELASA (Federation of European Laboratory Animal Science Associations Working Group on Health Monitoring of Rodent and Rabbit Colonies). Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim 2002;36:20-42.
17. Arras M, Huaux F, Vink A, Delos M, Coutelier J-P, Many M-C, Barbarin V, Renauld J-C, Lison D. Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. Am J Respir Cell Mol Biol 2001;24:368-375.
18. Lasfargues G, Lardot C, DelosM, Lauwerys R, Lison D. The delayed lung responses to single and repeated intratracheal administration of pure cobalt and hard metal powder in the rat. Environ Res 1995;69:108-121.
19. Kruger NJ. The Bradford method for protein quantitation. Methods Mol Biol 1994;32:9-15.
20. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 1992;24:145-149.
21. Corti A, Paolicchi A, Franzini M, Dominici S, Casini AF, Pompella A. The S-thiolating activity of membrane gamma-glutamyltransferase: formation of cysteinyl-glycine mixed disulfides with cellular proteins and in the cell microenvironment. Antioxid Redox Signal 2005;7:911-918.
22. Huseby NE, Strømme JH. Practical points regarding routine determination of gamma-glutamyl transferase (gamma-GT) in serum with a kinetic method at 37°C. Scand J Clin Lab Invest 1974;34:357-363.
23. Baker MA, Cerniglia GJ, Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 1990;190:360-365.
24. Legssyer R, Huaux F, Lebacq J, Delos M, Marbaix E, Lebecque P, Lison D, Scholte BJ, Wallemacq P, Leal T. Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice. Respir Res 2006;7:134-146.
25. Van der Wijk T, Blanchetot C, den Hertog J. Regulation of receptor protein-tyrosine phosphatase dimerization. Methods 2004;35:73-79.
26. Shirai T, Sato A, Chida K. Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity. Intern Med 1995;34:469-474.
27. Avila PC, Boushey HA. Macrolides, asthma, inflammation, and infection. Ann Allergy Asthma Immunol 2000;84:565-568.
28. Wales D, Woodhead M. The anti-inflammatory effects of macrolides. Thorax 1999;54:S58-S62.
29. Yamanaka Y, Tamari M, Nakahata T, Nakamura Y. Gene expression profiles of human small airway epithelial cells treated with low doses of 14- and 16-membered macrolides. Biochem Biophys Res Commun 2001;287:198-203.
30. Baumann U, King M, App EM, Tai S, Konig A, Fischer JJ, Zimmermann T, Sextro W, von derHardt H. Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties. Can Respir J 2004;11:151-155.
31. Hansen CR, Pressler T, Koch C, Hoiby N. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study. J Cyst Fibros 2005;4:35-40.
32. Jaffe A, Francis J, Rosenthal M, Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998;351:420.
33. Pirzada OM, McGaw J, Taylor CJ, Everard ML. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics. J Cyst Fibros 2003;2:69-71.
34. Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, Coquillette S, Fieberg AY, Accurso FJ, Campbell PW III; Macrolide Study Group. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003;290:1749-1756.
35. Saiman L, Mayer-Hamblett N, Campbell P, Marshall BC; Macrolide Study Group. Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis. Am J Respir Crit Care Med 2005;172:1008-1012.
36. Asgrimsson V, Gudjonsson T, Gudmundsson GH, Baldursson O. Novel effects of azithromycin on tight junction proteins in human airway epithelia. Antimicrob Agents Chemother 2006;50:1805-1812.
37. Pradal U, Delmarco A, Morganti M, Cipolli M, Mini E, Cazzola G. Long-term azithromycin in cystic fibrosis: another possible mechanism of action? J Chemother 2005;17:393-400.
38. Tsai WC, Rodriguez ML, Young KS, Deng JC, Thannickal VJ, Tateda K, Hershenson MB, Standiford TJ. Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am J Respir Crit Care Med 2004;170:1331-1339.
39. Flamant C, Henrion-Caude A, Boelle PY, Bremont F, Brouard J, Delaisi B, Duhamel JF, Marguet C, Roussey M, Miesch MC, et al. Glutathione-S- transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosis. Pharmacogenetics 2004;14:295-301.
40. Imboden M, Downs SH, Senn O, Matyas G, Brandli O, Russi EW, Schindler C, Ackermann-Liebrich U, Berger W, Probst-Hensch NM. SAPALDIA Team. Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study. Respir Res 2007;8:2-18.
41. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
42. Velsor LW, van Heeckeren A, Day BJ. Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am J Physiol Lung Cell Mol Physiol 2001;281:L31-L38.
43. Velsor LW, Kariya C, Kachadourian R, Day BJ. Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am J Respir Cell Mol Biol 2006;35:579-586.
44. Van Klaveren RJ, Hoet PH, Pype JL, Demedts M, Nemery B. Increase in gamma-glutamyltransferase by glutathione depletion in rat type II pneumocytes. Free Radic Biol Med 1997;22:525-534.
45. Calzado MA, Bacher S, Schmitz ML. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. Curr Med Chem 2007;14:367-376.
46. Kaur K, Sharma AK, Dhingra S, Singal PK. Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol 2006;41:1023-1030.
47. Tak PP, Firestein GS. NF-kB: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11.
48. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992;267:5317-5323.